USPTO trademark

ONEAAV

Under examinationUSPTOWord markClass 5Class 42

"ONEAAV" is a word mark owned by Coave Therapeutics, filed at the USPTO on August 14, 2026. It is under examination and covers classes 5 and 42.

Get this data via the API
Official USPTO record
ONEAAV trademark as filed
As filed with the USPTO
Status
Under examination
Since August 14, 2026
Filed
August 14, 2026
Registered
Not yet
Priority date
February 17, 2026
Claimed from France
Application no.
50052138
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns ONEAAV

The owner and representative on file with the office.

Owner

Coave Therapeutics

Paris, France

Representative

Pina Campagna

Carter, Deluca, & Farrell, LLP

Goods and services

What the mark covers

The products and services ONEAAV is filed for, grouped by Nice class.

  • Medicinal preparations for medical, pharmaceutical or veterinary use for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Chemical reagents for medical purposes; Chemical reagents for veterinary purposes; Biological reagents for medical purposes; Biological reagents for veterinary purposes; Biological preparations for use in cell cultures for medical purposes; Therapeutic biological preparations for use in targeted medical and clinical gene therapy, namely, for ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations for gene therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations for cellular therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Therapeutic biological preparations for use in the manufacture of pharmaceuticals

  • Research and development in the field of biotechnology and targeted gene therapy; Biological research in the field of targeted gene therapy systems and nucleic acid delivery systems; Pharmaceutical research and development; Biomedical research in the field of targeted gene therapy systems and nucleic acid delivery systems; Pharmaceutical research in the field of targeted gene therapy systems and nucleic acid delivery systems

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. New application office supplied data entered
  2. Application filing receipt mailed
  3. New application entered
FAQ

About ONEAAV

Who owns the trademark "ONEAAV"?

The USPTO trademark "ONEAAV" (application 50052138) is owned by Coave Therapeutics.

What is the status of "ONEAAV"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ONEAAV and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a00586-4124-73ad-8710-f0bc78fbac2c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a00586-4124-73ad-8710-f0bc78fbac2c",
  "object": "trademark",
  "mark_text": "ONEAAV",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50052138",
  "filing_date": "2026-08-14",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "COAVE THERAPEUTICS",
      "entity_id": null
    }
  ]
}